Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dynablend
- Development stage
- Unknown
- Lead developer
- Navana Pharmaceuticals
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
01
Overview
Dynablend is an aquaculture probiotic and enzyme formulation developed by Navana Pharmaceuticals. It is designed to improve poor pond-bottom surfaces, reduce ammonia and hydrogen sulfide levels, and break down organic sludge and food waste in aquaculture ponds. The formulation consists of a blend of beneficial bacteria (including *Bacillus subtilis*, *Bacillus licheniformis*, *Bacillus megaterium*, *Bacillus mesentericus*, *Bacillus coagulans*, and nitrifying and denitrifying bacteria), yeasts (*Saccharomyces cerevisiae* and *Saccharomyces boulardii*), digestive enzymes (such as protease, amylase, lipase, beta-glucanase, xylanase, and cellulase), and *Yucca schidigera* extract. In addition to water and soil quality management, Dynablend helps stabilize beneficial gut microbiota in aquatic species, preventing diseases such as black gills, tail rot, and necrosis of appendages.
- Brand names
- Dynablend
02
Targets
Urease
Beyond the preview
Go deeper on Dynablend.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dynablend.